Please contact us for more information or to learn if you are eligible to participate.
This research trial is testing an experimental drug called MK-3655 in people with liver disease called nonalcoholic steatohepatitis (NASH).
Principal Investigator | Fernando Membreno, MD |
Co-PI | Hiram Garcia Jr. |
Sponsor | Merck, Sharp, and Dohme LLC. |
Type of Trial | Interventional |